HIV

A look at last week's top stories in the world of pharmacy.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Brain damage can begin early in infection, particularly during untreated infection, and can cause cognitive impairment.

Top news of the day from across the health care landscape.

The FDA has approved once-daily oral emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (Truvada) in combination with safe sex practices, to reduce the risk of sexually acquired HIV-1 in at-risk adolescents..

This article highlights several key therapeutics areas with the prescription medication.

An HIV primary care program is working to reduce the number of new HIV diagnoses and increase viral suppression rates in Long Island and Queens.

The Conference on Retroviruses and Opportunistic Infections (CROI) annually assembles researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS, and related infectious diseases.

The development and uptake of antiretroviral therapy for HIV has reduced the risk of certain cancers were previously prevalent.

Only a small portion of latently infected cells are reactivated by latency-reversing agents.

Although current guidelines recommend that HIV primary care intervals do not exceed 6 months, gaps in care up to 9 months do not worsen viral load for patients.

HIV targets and disables a pathway involved in blocking viral activity and clearing infection.

People living with HIV are at elevated risk for hyponatremia, the most common electrolyte disorder seen in hospitals.

Legalizing the sale of syringes creates accessible, affordable, and reliable sources of sterile syringes for injection drug users (IDU).

Novel technique leverages limited DNA sequences from HIV to spark a priming effect within the patient’s immune response.

Some studies have suggested that patients with HIV have not only a higher risk of lung cancer, but also an increased risk of mortality from lung cancer than patients without HIV.

Velocity of change is key when it comes to falling sodium levels. Hyponatremia is the most common electrolyte disorder seen in hospitals.

Due to lack of data on menopause and HIV, many women living with HIV infection have limited access to medical care and support.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Advancing therapies have resulted in more women living with HIV who experience menopause. Unfortunately, many WLHIV fall into a knowledge gap.

Emergency departments are a safety net for low-income patients, many of whom may be at risk of HIV.

Mylan hopes to launch its newest HIV drug combo at a discounted cost.

Non-disclosure criminal prosecutions among gay, bisexual and other men who have sex with men have been increasing.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Health care providers should be aware of how HIV symptoms may affect menopausal women.

Lower respiratory infections remained the most lethal infectious disease in the United States.

Tenofovir alafenamide plus emtricitabine can be safely used as an alternative to abacavir plus lamivudine in patients with HIV.